Drug Evolution Process of IND, NDA & ANDA

Drug development is divided into types. The first type is Pre-clinical phase, usually takes 3 to 4 years to complete. If fruitful, this phase is followed by an appeal to the FDA as an Investigational New Drug (IND). After the approval by IND, the next stages are of clinical phases 1, 2, & 3, which require approximately 1-3 years for completion. Importantly, throughout the process of FDA, an investigator leading the clinical trials to communicate with each other so that safety is monitored. The manufacturer then files a New Drug Application (NDA) with the FDA for approval. This appeal can either be approved/ rejected; otherwise the FDA might request further study before making a quick decision. Following the acceptance, the FDA can also request the manufacturer to conduct additional post-marketing studies.  On average the entire process takes between 8 to 12 years.

  • IND China, Asia Pacific, USA, Globally
  • NDA China, Asia Pacific, USA, Globally
  • ANDA China, Asia Pacific, USA, Globally
  • Biologic License Application (BLA)
  • Current Status and Trends of IND/NDA Practices in China

Related Conference of Drug Evolution Process of IND, NDA & ANDA

November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
December 01-02, 2025

13th International Conference on Clinical Trials

Vancouver, Canada
January 29-30, 2026

19th World Drug Delivery Summit

Paris, France
February 10-11, 2026

40th World Congress on Pharmacology and Therapeutics

Barcelona, Spain
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, UK
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
March 24-25, 2026

11th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy

Drug Evolution Process of IND, NDA & ANDA Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in